![M. MacFarlane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
M.
David MacFarlane worked as an Independent Director at Titan Pharmaceuticals, Inc. from 2011 to 2023.
Prior to that, he was the Vice President of Regulatory Affairs at Genentech, Inc. from 1989 to 1999.
He also held the same position at Glaxo, Inc.
Eerdere bekende functies van M. MacFarlane
| Bedrijven | Functie | Einde |
|---|---|---|
| TITAN PHARMACEUTICALS | Directeur/Bestuurslid | 29-06-2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Algemeen Adviseur | 01-08-1999 |
Glaxo, Inc. | Algemeen Adviseur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
77
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Titan Pharmaceuticals, Inc.
 Titan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary therapeutics for the treatment of serious medical disorders | Health Technology |
Glaxo, Inc. |
